Skip to content
Independent analysis of NHS open data
PharmaInsight

Efavirenz/emtricitabine/tenofovir disoproxil vs Valaciclovir

National NHS prescribing compared (Prescription Cost Analysis)
Data updated September 2025

Valaciclovir was dispensed 6,824.0× as often as Efavirenz/emtricitabine/tenofovir disoproxil in September 2025 — 6,824 items versus 1 in England.

1items

Efavirenz/emtricitabine/tenofovir disoproxil · September 2025

NHSBSA Prescription Cost Analysis

6,824items

Valaciclovir · September 2025

NHSBSA Prescription Cost Analysis

Figure 1. Efavirenz/emtricitabine/tenofovir disoproxil versus Valaciclovir: national items dispensed by month

▬ Efavirenz/emtricitabine/tenofovir disoproxil   ·   ╌ Valaciclovir

0 3k 7k Jan 2021 Aug 2021 Apr 2022 Mar 2023 Jan 2024 Sep 2025 Valaciclovir 1 Jan 2021: 1 Mar 2021: 2 Jun 2021: 2 Jul 2021: 2 Aug 2021: 3 Dec 2021: 1 Feb 2022: 2 Mar 2022: 2 Apr 2022: 1 May 2022: 1 Jun 2022: 1 Nov 2022: 3 Mar 2023: 1 Jun 2023: 1 Jul 2023: 1 Aug 2023: 1 Jan 2024: 1 Feb 2024: 1 Mar 2024: 1 Apr 2024: 1 Jul 2024: 1 Oct 2024: 1 May 2025: 1 Sep 2025: 1

Source: NHSBSA Prescription Cost Analysis, to September 2025

Efavirenz/emtricitabine/tenofovir disoproxil versus Valaciclovir, September 2025
Measure Efavirenz/emtricitabine/tenofovir disoproxil Valaciclovir
Items, September 2025 1 6,824
Items, last 12 months 12 76,064
Net ingredient cost, September 2025 £533 £399,058

See the full profile for Efavirenz/emtricitabine/tenofovir disoproxil or Valaciclovir.